Arkansas Chapter
American Parkinson Disease
Association



If you would like to see things added to this web site, feel free to let us know.

Refer to the "Contact Us" page of the site to send us your suggestions.



ATTEND YOUR
LOCAL
SUPPORT GROUP

EDUCATION
IS THE
KEY TO
PARKINSON'S
MANAGEMENT!




NOTICE:
Plan Now To
Attend the
Fall Seminar:

Friday,
Sept. 24,
2010
Baptist Health Center
Little Rock

WHAT'S THE LATEST NEWS


NEWS FROM THE NATIONAL OFFICE OF THE APDA

If your traveling, espcially flying, and have been questioned about your condition, while going through security, there are now identification cards that the Transportation Security Administration acknowledges that includes Parkinson Disease. Please refer to this letter from the National Office of the APDA


Make plans now to attend the Fall Seminar. It will be held Friday, Septmenber 24 at Baptist Health Center in Little Rock. The schedule of speakers and registration form is now posted.

GET READY, THE ARKANSAS CHAPTER'S WALK-A-THON WILL BE SATURDAY, OCTOBER 16, 2010 AT THE HOT SPRINGS MALL. Make plans to ask your friends and co-workers for donations for research. This effort supports APDA's mission to "Find a Cure". More information and the pledge form will be available on this web site within the next few weeks.

The Fall Issue of the Arkansas Chapter's Newsletter is out!


Clinical Trials in Little Rock has a new study for Parkinson Patients who are currently taking Sinemet. Following is the description of the study and how to contact Clinical Trials if you are interested.

Parkinson's Disease (XP21279)

Our current study for Parkinson's is for patients diagnosed with Parkinson's disease aged 30-80. Must be taking carbidopa-levodopa (Sinemet) at least 4 times a day (400-1000mg) and on a stable dose for 4 weeks. Must be experiencing "off" periods (motor fluctuations) for at least 2 hours during the day. Cannot be taking Sinemet CR, Stalevo, Entacapone, Comtan, Parcopa, Tasmar, Madopar or Prolopa (this is only a partial list of excluded medications). This study is 2 months with 13 office visits including 2 overnight stays. This study is evaluating the safety and effectiveness of an investigational drug which may reduce motor fluctuations and dyskinesias. It is an investigational form of an oral medication for Parkinson's Disease. There is no cost to participate and the patient/caregiver participation is voluntary. There may be some reimbursement for time and travel. Contact Clinical Trials, Inc. at 501-227-6179 to see if you or a loved one might qualify. For email inquiries, contact info@clinicaltrialsinc.com, or go to visit www.clinicaltrialsinc.com


NEW STUDY ON PARKINSON'S DISEASE AND BARRIERS TO MENTAL HEALTH CARE UTILIZATION

The Robert Wood Johnson Medical School - University of Medicine and Denistry of New Jersey, is conducting a study, funded by the National Institute of Health, in order to better understand the difficulties that PD patients may experience using the mental health care system. Anyone who might be interested should see the flier.

OUR MISSION

The Arkansas Chapter of the American Parkinson Disease Association is here to EDUCATE and ASSIST those in the state with Parkinson Disease. The APDA's motto of "To ease the burden and find a cure" is evident in the Arkansas Chapter's activities.
To that end, we sponsor and support 23 Support Groups throughout the state, and conduct 2 all day seminars each year, as well as in-service training for professionals.
This web site is to help those who are newly diagnosed find a local support group and more information on PD and the resources available to them. For those who already belong to a support group, hopefully this web site will help you stay better connected, know what's going on in our state, and learn new things about Parkinson Disease.

Visit your local support group. No group meets in your area? Contact us on how to start one. They're a great way to learn about the disease and how to manage it, and discuss what you've learned with others.